Latest News
Roche Diagnostics supplies molecular testing instruments to support Ebola response in the DRC
7 October 2026 - Swiss healthcare company Roche (SIX: RO, ROP; OTCQX: RHHBY) announced on Wednesday that it has supplied two molecular testing instruments to the Institut National de Santé Publique (INSP) to expand Ebola testing capacity in th...
ABIONYX Pharma partners with OLON to prepare CER-001 for regulatory approval and potential commercial supply
7 October 2026 - ABIONYX Pharma (Euronext Paris:ABNX), a biopharma company focused on breakthrough biotherapies to address life-threatening conditions with no effective treatments, announced on Wednesday that it has entered into a strategic manufactu...
Kedrion to be honoured at Premier's Supplier Innovation Celebration
7 October 2026 - Plasma-derived therapies company Kedrion Biopharma announced on Tuesday that it will be honoured by Premier Inc, a technology-driven healthcare improvement company, during the annual Supplier Innovation Celebration at its 2026 Breakt...
Enliven Therapeutics reaches FDA alignment on relcobatinib (ELVN-001) Phase 3 trial design for previously treated CML
7 October 2026 - Enliven Therapeutics Inc (Nasdaq:ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, announced on Tuesday that it has reached alignment with the US Food and Drug ...
Accuray reports stockholder approval of financing-related proposals and appointment of independent director
7 October 2026 - Accuray Incorporated (Nasdaq:ARAY), a provider of radiation therapy accessories, announced on Tuesday that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on 6 October 2026, en...